Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis
Lei Zhang1, Wei-Qiang Tan2, Qing-Qing Fang3
1Department of Orthopaedics, Xiaoshan Hospital of Traditional Chinese Medicine, Hangzhou 311201, China.
Objective:
Melasma is a highly prevalent, chronic, and pigmentary disorder. This systematic review aims to evaluate the efficacy and safety of tranexamic acid (TA) for the treatment of adults with melasma.
Methods:
We independently searched 3 databases from beginning to 26 April, 2018. The study included 21 eligible trials. Two writers extracted data at the same time independently. Study outcomes were calculated by standardized mean differences (SMD) with 95% confidence intervals (CIs). All statistical analyses were performed using Review Manager Version 5.3 and STATA Version 15.1.
Results:
The combined results showed that the use of TA was associated with reduced Melasma Area and Severity Index (MASI) and Melanin Index (MI). No significant difference in Erythema Index (EI) was observed with TA treatment. Side effects were minor, with a few cases reporting mild gastrointestinal reaction, oligomenorrhoea, hypopigmentation, urticarial rash, and skin irritation xerosis.
Conclusion:
The meta-analysis suggested that TA treatment appeared to be a promising therapeutic approach for melasma.
Insights
Tranexamic acid (TA) effectively reduces melasma severity, as indicated by lower Melasma Area and Severity Index (MASI) scores. While generally safe, minor side effects like gastrointestinal upset were reported in this systematic review.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Melasma is a common, persistent skin pigmentation disorder.
- Effective and safe treatments are sought for melasma management.
Purpose of the Study:
- To systematically review and evaluate the efficacy and safety of tranexamic acid (TA) for treating adult melasma.
Main Methods:
- A systematic review and meta-analysis of 21 eligible trials.
- Data independently extracted and analyzed using standardized mean differences (SMD) with 95% confidence intervals (CIs).
- Searched 3 databases up to April 26, 2018.
Main Results:
- Tranexamic acid (TA) significantly reduced Melasma Area and Severity Index (MASI) and Melanin Index (MI).
- No significant changes were observed in the Erythema Index (EI).
- Reported side effects were minor, including mild gastrointestinal reactions and skin irritation.
Conclusions:
- Tranexamic acid (TA) shows promise as a therapeutic option for melasma.
- The treatment is associated with a favorable safety profile.
More Related Videos
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error

